{"id":"W2124433242","doi":"10.3816/clm.2009.n.019","title":"Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia","year":2009,"lang":"en","type":"review","venue":"Clinical Lymphoma & Myeloma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saskatchewan Cancer Agency; Queen Elizabeth II Health Sciences Centre; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Bortezomib; Medicine; Waldenstrom macroglobulinemia; Macroglobulinemia; Proteasome inhibitor; Multiple myeloma; Refractory (planetary science); Oncology; Internal medicine; Peripheral neuropathy; Lymphoma; Endocrinology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.00297826,0.001507622,0.008663293,0.0007916883,0.0001250899,0.0001078448,0.001421384,0.003728955,0.001070274],"category_scores_gemma":[0.006902487,0.001081896,0.002686784,0.001908183,0.0008320931,0.0001181799,0.0005958314,0.002395162,0.003265561],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02871709,"about_ca_system_score_gemma":0.06279638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002275793,"about_ca_topic_score_gemma":0.0001249573,"domain_scores_codex":[0.9867339,0.001208497,0.006006856,0.002504284,0.001588901,0.001957637],"domain_scores_gemma":[0.9891852,0.004527345,0.001267493,0.003260122,0.0002988665,0.001461044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001250664,0.001245864,0.00006389017,0.0091761,0.000324126,0.02010521,0.00001803846,1.775186e-7,1.695088e-7,0.00003981879,0.01516511,0.9526109],"study_design_scores_gemma":[0.02500807,0.00173875,0.001201482,0.03102119,0.001275177,0.00729032,0.00001691737,0.0002039494,0.000001001713,0.00005352185,0.9311824,0.001007252],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002950988,0.9858946,0.000002390747,0.0001899255,0.001102448,0.0031433,0.00007411447,0.0003452605,0.006297034],"genre_scores_gemma":[0.000226052,0.9806894,0.00105974,0.001026808,0.002661872,0.0002264107,0.0003651348,0.0003367251,0.01340782],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9516036,"threshold_uncertainty_score":0.9999064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1287236890803222,"score_gpt":0.4669914693417026,"score_spread":0.3382677802613804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}